Prostate carcinoma and green tea: (-)Epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine tramp model

International Journal of Cancer

Volumn 112, Issue 5, 2004, Pages 823-829

  Sartor, Luigi ^a   Pezzato, Elga ^a   Donà, Massimo ^a   Dell'Aica, Isabella ^a   Calabrese, Fiorella ^a   Morini, Monica ^b   Albini, Adriana ^b   Garbisa, Spiridione ^a,c  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

EGCG; Invasion; MMP 2 activation; Neutrophils; Proliferation; Prostate carcinoma; TRAMP

Indexed keywords

CHEMOATTRACTANT; EPIGALLOCATECHIN GALLATE; FLAVANOID; GELATINASE A; GELATINASE B; GREEN TEA EXTRACT; LIPOPOLYSACCHARIDE; MATRIGEL;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DISPERSION; DOSE RESPONSE; DRUG EFFECT; EMBRYO; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME RELEASE; IC 50; IMMUNOLOCALIZATION; INCUBATION TIME; INFLAMMATION; MALE; MOUSE; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; TEA;

ADENOCARCINOMA; ANIMALS; ANTICARCINOGENIC AGENTS; CATECHIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 2; MICE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; TEA;

EID: 7244243792     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20496     Document Type: Article

References (31)

1. Grönberg H. Prostate cancer epidemiology. Lancet 2003;361:859-64.
2. Satariano WA, Ragland KE, Van Den Eeden SK. Cause of death in men diagnosed with prostate carcinoma. Cancer 1998;83:1180-8.
3. Boyle P, D'Onofrio A, Maisonneuve P, Seven G, Robertson C, Tubiana M, Veronesi U. Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about? Ann Oncol 2003;14:1312-25.
4. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-74.
5. Sato H, Okada Y, Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Thromb Haemost 1997;78:497-500.
6. Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, Mignatti P. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J 1997;16:2319-32.
7. Pezzato E, Donà M, Sartor L, Dell'Aica I, Benelli R, Albini A, Garbisa S. Proteinase-3 directly activates gelatinase A, and degrades gelatin and Matrigel; differential inhibition by (-)epigallocatechin-3-gallate. J Leukocyte Biol 2003;74:88-94.
8. Beekman B, Drijfhout JW, Ronday HK, TeKoppele JM. Fluorogenic MMP activity assay for plasma including MMPs complexed to alpha 2-macroglobulin. Ann N Y Acad Sci 1999;878:150-8.
9. Upadhyay J, Shekarriz B, Nemeth JA, Dong Z, Cummings GD, Fridman R, Sakr W, Grignon DJ, Cher ML. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia. Clin Cancer Res 1999;5: 4105-10.
10. Wilson MJ, Sellers RG, Wiehr C, Melamud O, Pei D, Peehl DM. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. J Cell Physiol 2002;191: 208-16.
11. Shamamian P, Schwartz JD, Pocock BJZ, Monea S, Whiting D, Marcus SG, Mignatti P. Activation of pro gelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol 2001;189:197-206.
12. Ludwig M, Vidal A, Diemer T, Pabst W, Failing K, Weidner W. Chronic prostatitis/chronic pelvic pain syndrome: seminal markers of inflammation. World J Urol 2003;21:82-5.
13. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45.
14. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev-Cancer 2003;3:276-85.
15. Sternlicht MD, Werb Z. Neutrophil elastase and cathepsin G. In: Kreis T, Vale R, eds. Extracellular matrix, anchor, and adhesion proteins. Oxford: Oxford University Press. 1999. 543-45.
16. Garbisa S, Biggin S, Cavallarin N, Sartor L, Benelli R, Albini A. Tumor invasion: molecular shears blunted by green tea. Nat Med 1999;5:1216.
17. Dell'Aica I, Donà M, Sartor L, Pezzato E, Garbisa S. (-)Epigallocatechin-3-galiate directly inhibits MT1-MMP activity, leading to accumulation of non-activated MMP-2 at the cell surface. Lab Invest 2002;82:1685-94.
18. Sartor L, Pezzato E, Garbisa S. (-)Epigallocatechin-3-gallate inhibits leukocyte elastase: potential of the phytofactor in hindering inflammation, emphysema, and invasion. J Leukocyte Biol 2002;71:73-9.
19. Donà M, Dell'Aica I, Calabrese F, Benelli R, Morini M, Albini A, Garbisa S. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis and pulmonary fibrosis. J Immunol 2003;170:4335-41.
20. Garbisa S, Sartor L, Biggin S, Salvato B, Benelli R, Albini A. Tumor gelatinase and invasion inhibited by the green tea flavonol epigallo-catechin-3- gallate. Cancer 2001;91:822-32.
21. Jian L, Xie LP, Lee AH, Binns CW. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer 2004;108:130-5.
22. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 2001;98:10350-5.
23. Foster BA, Gingrich JR, Kwon ED, Madias C, Greenberg NM. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res 1997;57:3325-30.
24. Dri P, Haas E, Cramer R, Menegazzi R, Gasparini C, Martinelli R, Scheurich P, Patriarca P. Role of the 75-kDa TNF receptor in TNF-induced activation of neutrophil respiratory burst. J Immunol 1999; 162:460-6.
25. Yang CS, Landau JM, Huang MT, Newmarck HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 2001;21:381-406.
26. Adhami VM, Ahmad N, Mukhtar H. Molecular targets for green tea in prostate cancer prevention. J Nutr 2003;133:2417-24.
27. Lambert JD, Yang CS. Cancer chemopreventive activity and bioavailability of tea polyphenols. Mutat Res 2003;523:201-8.
28. Ahmad N, Feyes DK, Nieminen AL, Agerwal R, Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 1997;89:1881-6.
29. Liang JC, Lin-Schiau SY, Chen CF, Lin JK. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of CDK inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)epigallocatechin-3- gallate. J Cell Biochem 1999;75: 1-12.
30. Gupta S, Ahmad N, Nieminen AL, Mukhtar H. Toxicol. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Appl Pharmacol 2000;164:82-90.
31. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003;349:366-81.